Biotechnology — Gene delivery systems — Part 2: Quantification methods for viral vectors
Introduction: Modern biotechnology relies on the ability to manipulate genes and genomes in living systems. Gene delivery systems are foundational to genome engineering. Gene delivery technology is evolving rapidly with numerous types of gene delivery systems providing a comprehensive set of tools and capabilities for in vitro or in vivo targeted delivery. The ISO 16921 series consists of multiple parts to provide common understanding, guides, analytical methods and, data reporting for characterizing these emerging biotechnology tools. ISO 16921-1 specifies Vocabulary related to gene delivery systems. This document (ISO 16921-2) focuses on quantification of one type of gene delivery system, viral vectors. Viral vectors are engineered viruses for delivering the desired genetic payload into target cells. Viral vectors are powerful molecular biology tools and have been increasingly used in broad biotechnology applications and products. Various types of viral vectors are used as advanced gene therapies, as vaccines, and as critical reagents for cellular therapies. They have also been increasingly used in genome editing applications. Viral vector titer (titre) is central to all applications. Robust measurements for the quantification and reporting of viral vector titer are important for the industry. This document provides general guidance for viral vector titer as well as aspects of functional analysis including method selection, sample preparation, measurement, qualification and validation, d
Scope: This document specifies minimum requirements for quantifying viral vectors in terms of physical titer and their associated activity. This document specifies key considerations for quantification methods for viral vector titer as well as activity, including method selection, measurement process, data analysis, and reporting.